Additionally, serum Endostatin levels have shown significant correlations with hemodynamics, NT-proBNP, and 6MWD, further supporting its potential as a biomarker for disease progression and poor prognosis in PAH. This evidence concerns the gene NPPB and pulmonary arterial hypertension.